Across TCGA pan-cancer cohorts, SFTA3 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated SFTA3 data layer compared with 19 for mass-spec protein.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher SFTA3 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated SFTA3 expression acts as an unfavorable survival marker.

SKCM and SARC are the cancer types where SFTA3 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Median	II,III,IV	0.230	0.850	<.001	19	view →
SARC	OS	Median	All	0.032	0.861	<.001	12	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: SFTA3 tumor-vs-normal RNA expression · all SFTA3 data types